PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 59 filers reported holding PREVAIL THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $348,000 | +117.5% | 15,100 | -3.8% | 0.00% | – |
Q3 2020 | $160,000 | -31.6% | 15,700 | 0.0% | 0.00% | – |
Q2 2020 | $234,000 | +110.8% | 15,700 | +72.5% | 0.00% | – |
Q1 2020 | $111,000 | -22.9% | 9,100 | 0.0% | 0.00% | – |
Q4 2019 | $144,000 | +1340.0% | 9,100 | +1037.5% | 0.00% | – |
Q3 2019 | $10,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 13,822,463 | $205,955,000 | 2.90% |
Avidity Partners Management LP | 1,028,800 | $15,329,000 | 0.98% |
Omega Fund Management, LLC | 187,538 | $2,794,000 | 0.76% |
Boxer Capital, LLC | 1,123,105 | $16,734,000 | 0.74% |
RA Capital Management | 2,494,691 | $37,171,000 | 0.72% |
EcoR1 Capital, LLC | 367,218 | $5,472,000 | 0.40% |
QVT Financial LP | 133,690 | $1,992,000 | 0.34% |
DAFNA Capital Management LLC | 75,000 | $1,118,000 | 0.32% |
Woodline Partners LP | 329,135 | $4,904,000 | 0.19% |
Virtus ETF Advisers LLC | 22,460 | $335,000 | 0.16% |